S1PR2

Chr 19AR

sphingosine-1-phosphate receptor 2

Also known as: AGR16, DFNB68, EDG-5, EDG5, Gpcr13, H218, LPB2, S1P2

This gene encodes a member of the G protein-coupled receptors, as well as the EDG family of proteins. The encoded protein is a receptor for sphingosine 1-phosphate, which participates in cell proliferation, survival, and transcriptional activation. Defects in this gene have been associated with congenital profound deafness. [provided by RefSeq, Mar 2016]

OMIMResearchGenerating clinical summary…
MultiplemechanismARLOEUF 1.041 OMIM phenotype
Clinical SummaryS1PR2
🧬
Gene-Disease Validity (ClinGen)
nonsyndromic genetic hearing loss · ARStrong

Strong evidence — appropriate for clinical testing

Population Constraint (gnomAD)
Low constraint (pLI 0.02) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
2 unique Pathogenic / Likely Pathogenic· 69 VUS of 144 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.04LOEUF
pLI 0.018
Z-score 1.49
OE 0.46 (0.221.04)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
1.53Z-score
OE missense 0.72 (0.640.82)
173 obs / 239.5 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.46 (0.221.04)
00.351.4
Missense OE?0.72 (0.640.82)
00.61.4
Synonymous OE?0.89
01.21.6
LoF obs/exp: 4 / 8.8Missense obs/exp: 173 / 239.5Syn Z: 0.92

This gene — mechanism propensity

DN
0.73top 25%
GOF
0.85top 5%
LOF
0.2581th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

144 submitted variants in ClinVar

Classification Summary

Pathogenic2
VUS69
Likely Benign53
Benign11
Conflicting6
2
Pathogenic
69
VUS
53
Likely Benign
11
Benign
6
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
2
0
0
2
Likely Pathogenic
0
0
0
0
0
VUS
0
68
0
1
69
Likely Benign
0
5
3
45
53
Benign
0
1
3
7
11
Conflicting
6
Total076653141

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

9 pathogenic / likely-pathogenic (of 11) ClinVar copy-number / structural variants overlap S1PR2 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

S1PR2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →